Related Experiment Video
Updated: Aug 9, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Initial single-center experience of a standardized protocol for invasive assessment of ischemia and non-obstructive
Vera Vaz Ferreira1, Ruben Ramos1, Alexandra Castelo1
1Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Insights
A comprehensive coronary function test (CFT) is safe and feasible for diagnosing coronary vasomotion disorders (CVDs) like microvascular angina (MVA) and vasospastic angina (VSA) in patients with non-obstructive coronary artery disease (NOCAD). This test helps guide treatment for persistent angina.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Coronary vasomotion disorders (CVDs), encompassing microvascular angina (MVA) and vasospastic angina (VSA), contribute significantly to morbidity in patients with non-obstructive coronary artery disease (NOCAD).
- Current clinical protocols for CVD assessment lack standardization and can be challenging to implement, leading to diagnostic delays and suboptimal patient management.
Purpose of the Study:
- To evaluate the safety and feasibility of a comprehensive coronary function test (CFT) protocol for diagnosing CVDs.
- To determine the prevalence of various CVD phenotypes in patients experiencing angina despite having non-obstructive coronary artery disease (ANOCA).
Main Methods:
- Prospective recruitment of patients with persistent angina and NOCAD undergoing invasive coronary angiography.
- Performance of a comprehensive coronary function test (CFT) including assessment of fractional flow reserve, coronary flow reserve, index of myocardial resistance, and coronary vasoreactivity.
Main Results:
- The CFT was successfully and safely performed in all 20 participants (mean age 63±13 years, 50% female) without complications.
- Prevalence of CVD phenotypes included isolated MVA (25%), isolated VSA (40%), mixed MVA and VSA (10%), and non-cardiac chest pain (25%).
- CFT results led to antianginal therapy modification in 70% of patients.
Conclusions:
- A comprehensive coronary function test (CFT) is a feasible and safe diagnostic tool for patients with angina and non-obstructive coronary artery disease (ANOCA).
- CVDs are highly prevalent in this patient group, with a significant proportion exhibiting mixed phenotypes.
- CFT enables definitive diagnosis and guides pharmacological therapy stratification for persistent angina.
Introduction:
Coronary vasomotion disorders (CVDs), including microvascular angina (MVA) and vasospastic angina (VSA), account for significant morbidity among patients with non-obstructive coronary artery disease (NOCAD). However, protocols for CVD assessment in clinical practice are seldom standardized and may be difficult to implement.
Purpose:
To assess the safety and feasibility of a comprehensive coronary function test (CFT) protocol for assessment of CVD and the prevalence of different phenotypes of CVD in patients with angina and NOCAD (ANOCA).
Methods:
Patients with persistent angina referred for invasive coronary angiogram and found to have NOCAD were prospectively recruited and underwent a CFT. Functional parameters (fractional flow reserve, coronary flow reserve and index of myocardial resistance) and coronary vasoreactivity were assessed in all patients.
Results:
Of the 20 patients included, the mean age was 63±13 years and 50% were females. Most patients had persistent typical angina and evidence of ischemia in noninvasive tests (75%). The CFT was successfully performed in all subjects without serious complications. Isolated MVA was found in 25%, isolated VSA in 40%, both MVA and VSA in 10% and noncardiac chest pain in 25% of patients. Antianginal therapy was modified after the results of CFT in 70% of patients.
Conclusion:
A coronary function test was feasible and safe in a cohort of patients with ANOCA. CVD were prevalent in this selected group of patients, and some presented mixed CVD phenotypes. CFT may provide a definitive diagnosis in patients with persistent angina and prompt the stratification of pharmacological therapy.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
Cardiac Catheterization III: Left Heart Catheterization

